Literature DB >> 15973124

Methods to avoid infections in patients with inflammatory bowel disease.

Faten N Aberra1, Gary R Lichtenstein.   

Abstract

Infections have been reported in patients with inflammatory bowel disease (IBD), especially in association with anti-inflammatory and immunomodulatory medications used to treat IBD. Unfortunately, there is a dearth of information on infectious complication risk in patients with IBD. This review describes infectious complications reported in patients with IBD and provides a framework for future studies to assess potential risk factors and incidence for infection. Recommendations are also provided for prevention of infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15973124     DOI: 10.1097/01.mib.0000160742.91602.b7

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  17 in total

1.  Risk of Clostridium difficile Infection in Patients With Celiac Disease: A Population-Based Study.

Authors:  Benjamin Lebwohl; Yael R Nobel; Peter H R Green; Martin J Blaser; Jonas F Ludvigsson
Journal:  Am J Gastroenterol       Date:  2017-10-31       Impact factor: 10.864

2.  Booster influenza vaccination does not improve immune response in adult inflammatory bowel disease patients treated with immunosuppressives: a randomized controlled trial.

Authors:  Hiroko Matsumoto; Satoko Ohfuji; Kenji Watanabe; Hirokazu Yamagami; Wakaba Fukushima; Kazuhiro Maeda; Noriko Kamata; Mitsue Sogawa; Masatsugu Shiba; Tetsuya Tanigawa; Kazunari Tominaga; Toshio Watanabe; Yasuhiro Fujiwara; Yoshio Hirota; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2015-02-12       Impact factor: 7.527

Review 3.  Preventing infective complications in inflammatory bowel disease.

Authors:  Justine Mill; Ian C Lawrance
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 4.  Adverse events in IBD: to stop or continue immune suppressant and biologic treatment.

Authors:  Leon P McLean; Raymond K Cross
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2014-02-04       Impact factor: 3.869

Review 5.  Long-term safety of immunomodulators in pediatric inflammatory diseases.

Authors:  Federica Nuti; Fortunata Civitelli; Salvatore Cucchiara
Journal:  Paediatr Drugs       Date:  2014-10       Impact factor: 3.022

6.  Refractory ulcerative colitis treatment.

Authors:  Richard P Macdermott; Jesse A Green
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-01

7.  Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines.

Authors:  Iris Dotan; Lael Werner; Sharon Vigodman; Shradha Agarwal; Jorge Pfeffer; Noya Horowitz; Lisa Malter; Maria Abreu; Thomas Ullman; Hanan Guzner-Gur; Zamir Halpern; Lloyd Mayer
Journal:  Inflamm Bowel Dis       Date:  2011-03-15       Impact factor: 5.325

8.  Prevention of infection caused by immunosuppressive drugs in gastroenterology.

Authors:  Katarzyna Orlicka; Eleanor Barnes; Emma L Culver
Journal:  Ther Adv Chronic Dis       Date:  2013-07       Impact factor: 5.091

9.  Vaccination and Health Maintenance Issues to Consider in Patients With Inflammatory Bowel Disease.

Authors:  Jason Reich; Sharmeel K Wasan; Francis A Farraye
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-12

10.  Evaluation of antibody response to polysaccharide vaccine and switched memory B cells in pediatric patients with inflammatory bowel disease.

Authors:  Gholamhossein Fallahi; Asghar Aghamohammadi; Ahmad Khodadad; Mojtaba Hashemi; Payam Mohammadinejad; Hossein Asgarian-Omran; Mehri Najafi; Fatemeh Farhmand; Farzaneh Motamed; Khadije Soleimani; Habib Soheili; Nima Parvaneh; Behzad Darabi; Rasoul Nasiri Kalmarzi; Shabnam Pourhamdi; Hassan Abolhassani; Babak Mirminachi; Nima Rezaei
Journal:  Gut Liver       Date:  2013-08-14       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.